Novo Nordisk

Clinical News

Oral semaglutide as effective as injectable

David Rowley 29/05/2023

Ozempic/Wegovy sponsor trumpets results of Phase III clinical trial as its halts US ads A trial of an oral version of Novo Nordisk’s obesity and diabetes medication semaglutide, the active …

News

No Ozempic until end of March 2023: TGA

David Rowley 07/11/2022

TGA says the diabetes drug will be unavailable from mid-November until end of March next year – but drug company’s message is not quite so bleak The lingering months-long shortage …

This web site is intended for Australian pharmacy professionals and is not a substitute for independent professional advice. Information and interactions contained in this website are for information purposes only and are not intended to be used to diagnose, treat, cure or prevent any disease. Further the accuracy, currency and completeness of the information available on this web site cannot be guaranteed. APPco Pty Ltd, its affiliates and their respective servants and agents do not accept any liability for any injury, loss or damage incurred by use of or reliance on the information made available via or through ajp.com.au whether arising from negligence or otherwise.

Oral semaglutide as effective as injectable

No Ozempic until end of March 2023: TGA

MENU

ajp.com.au

Tags

Hi there! 👋 Looks like you’re not logged in.